Details for Patent: 5,972,990

Summary for Patent: 5,972,990

Title:	Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
Abstract:	The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.
Inventor(s):	Pfeffer; Marc A. (Chestnut Hill, MA), Pfeffer; Janice M. (Chestnut Hill, MA), Braunwald; Eugene (Weston, MA)
Assignee:	Brigham and Women's Hospital, Inc. (Boston, MA)
Application Number:	07/981,196
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 5,972,990

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 5,972,990

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	4281093
Canada	2117782
Germany	69333362
Denmark	0641218
European Patent Office	0641218
European Patent Office	1262175